DD201599A5 - Verfahren zur herstellung von cephalosporinen - Google Patents

Verfahren zur herstellung von cephalosporinen Download PDF

Info

Publication number
DD201599A5
DD201599A5 DD82238001A DD23800182A DD201599A5 DD 201599 A5 DD201599 A5 DD 201599A5 DD 82238001 A DD82238001 A DD 82238001A DD 23800182 A DD23800182 A DD 23800182A DD 201599 A5 DD201599 A5 DD 201599A5
Authority
DD
German Democratic Republic
Prior art keywords
cephem
aminothiazol
hydroxy
methyl
preparation
Prior art date
Application number
DD82238001A
Other languages
German (de)
English (en)
Inventor
William H W Lunn
John K Shadle
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DD201599A5 publication Critical patent/DD201599A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD82238001A 1981-03-11 1982-03-09 Verfahren zur herstellung von cephalosporinen DD201599A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/242,792 US4336253A (en) 1981-03-11 1981-03-11 Cephalosporin antibiotics

Publications (1)

Publication Number Publication Date
DD201599A5 true DD201599A5 (de) 1983-07-27

Family

ID=22916202

Family Applications (1)

Application Number Title Priority Date Filing Date
DD82238001A DD201599A5 (de) 1981-03-11 1982-03-09 Verfahren zur herstellung von cephalosporinen

Country Status (21)

Country Link
US (1) US4336253A (fr)
EP (1) EP0060144A3 (fr)
JP (1) JPS57165393A (fr)
KR (1) KR830009119A (fr)
AU (1) AU8091182A (fr)
BG (1) BG36936A3 (fr)
CA (1) CA1177066A (fr)
CS (1) CS238620B2 (fr)
DD (1) DD201599A5 (fr)
DK (1) DK100982A (fr)
ES (1) ES8303426A1 (fr)
FI (1) FI820806A7 (fr)
GB (1) GB2094309B (fr)
GR (1) GR74714B (fr)
IL (1) IL65185A0 (fr)
NZ (1) NZ199959A (fr)
PH (1) PH17022A (fr)
PL (1) PL130568B1 (fr)
PT (1) PT74558B (fr)
RO (1) RO82962B (fr)
ZA (1) ZA821525B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443444A (en) * 1980-08-11 1984-04-17 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
US4450270A (en) * 1981-10-02 1984-05-22 Eli Lilly And Company Dioximino cephalosporin antibiotics
US4616081A (en) * 1982-07-07 1986-10-07 Asahi Kasei Kogyo Kabushiki Kaisha Cephalosporin compounds
DE3316797A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
DE3316798A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
ATE177104T1 (de) * 1984-11-23 1999-03-15 Biochemie Gmbh Cephalosporinderivative
US4703118A (en) * 1985-04-08 1987-10-27 Eli Lilly And Company Synthesis of 3-iodomethyl cephalosporins
US4714760A (en) * 1985-08-20 1987-12-22 Bristol-Myers Company Cephalosporin intermediates
US4749522A (en) * 1985-10-31 1988-06-07 Angio-Medical Corporation Supercritical fluid extraction of animal derived materials
US4868294A (en) * 1986-07-11 1989-09-19 Bristol-Myers Company Process for preparing cephalosporin intermediates
US7847093B2 (en) * 2003-04-16 2010-12-07 Sandoz Ag Processes for the preparations of cefepime
DE602004028111D1 (de) 2003-04-16 2010-08-26 Sandoz Ag Verfahren zur herstellung von cefepim
EP1773845A1 (fr) * 2004-07-16 2007-04-18 Hetero Drugs Limited Procede de preparation d'intermediaires de cephalosporine pures
WO2013036783A2 (fr) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Procédés de traitement d'infections intrapulmonaires
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
KR102329764B1 (ko) 2013-03-15 2021-11-23 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792047A (en) * 1971-12-07 1974-02-12 Glaxo Lab Ltd N-(7,2'-thienylacetamidoceph-3-em-3-ylmethyl)-3"or 4"-n-hydroxyloweralkylcarbamoyl-pyridinium-4-carboxylates
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
DE2760484C2 (fr) * 1976-04-14 1992-12-03 Takeda Chemical Industries, Ltd., Osaka, Jp
JPS52125188A (en) 1976-04-14 1977-10-20 Takeda Chem Ind Ltd Cephalosporin derivatives and their preparation
JPS6011713B2 (ja) * 1976-09-08 1985-03-27 武田薬品工業株式会社 セフアロスポリン誘導体およびその製造法
KR830000606B1 (ko) 1978-05-26 1983-03-17 헤롤드 월터 마틴 세팔로스포린 항생제의 제조방법
GB2027692B (en) 1978-05-26 1983-02-09 Glaxo Group Ltd Cephalosporin antibiotics
AR229883A1 (es) * 1978-05-26 1983-12-30 Glaxo Group Ltd Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato
ES8103103A1 (es) 1979-02-23 1981-02-16 Glaxo Group Ltd Un procedimiento para la preparacion de un antibiotico de cefalosporina.
US4237128A (en) * 1979-04-12 1980-12-02 E. R. Squibb & Sons, Inc. 7-[2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1,1-dialkyl)alkoxyimino]acetamido]cephem sulfoxides

Also Published As

Publication number Publication date
EP0060144A3 (fr) 1983-09-14
KR830009119A (ko) 1983-12-17
FI820806L (fi) 1982-09-12
AU8091182A (en) 1982-09-16
ZA821525B (en) 1983-03-30
CA1177066A (fr) 1984-10-30
PT74558B (en) 1984-11-27
JPS57165393A (en) 1982-10-12
IL65185A0 (en) 1982-05-31
NZ199959A (en) 1985-08-16
PT74558A (en) 1982-04-01
ES510307A0 (es) 1983-02-01
GR74714B (fr) 1984-07-06
PH17022A (en) 1984-05-11
ES8303426A1 (es) 1983-02-01
GB2094309B (en) 1985-03-27
PL130568B1 (en) 1984-08-31
RO82962A (fr) 1984-01-14
DK100982A (da) 1982-09-12
EP0060144A2 (fr) 1982-09-15
CS238620B2 (en) 1985-12-16
RO82962B (ro) 1984-01-30
GB2094309A (en) 1982-09-15
US4336253A (en) 1982-06-22
PL235396A1 (fr) 1982-09-27
FI820806A7 (fi) 1982-09-12
BG36936A3 (bg) 1985-02-15

Similar Documents

Publication Publication Date Title
US4336253A (en) Cephalosporin antibiotics
DE3851749T2 (de) Verfahren zur Herstellung von 3-hydrocarbyl-3-cephemverbindungen.
CH630632A5 (de) Verfahren zur herstellung neuer cephalosporinderivate.
CH634578A5 (de) Verfahren zur herstellung von neuen cephalosporinderivaten.
DE3404615A1 (de) Cephalosporinverbindungen, verfahren zu deren herstellung und sie enthaltende, pharmazeutische mittel
DE3236065A1 (de) Dioximinocephalosporine
CH639666A5 (de) Cephalosporansaeurederivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung.
DE2439880B2 (de) (6R, 7R)-3-Carbamoyloxymethyl-7- [2-(fur-2-yl)-2methoxyiminoacetamido] -ceph-S-em^carbonsäure und Verfahren zur ihrer Herstellung
DE3512225C2 (fr)
DE3233377A1 (de) Cephalosporinisochinoliniumbetaine und sie enthaltende pharmazeutische mittel
DE3236066A1 (de) Pyraziniumcephalosporine
EP0280157B1 (fr) Sels d'addition cristallins de dérivés céphem et procédé pour leur préparation
CH647784A5 (de) Cephalosporinantibiotika.
DD139857A5 (de) Verfahren zur herstellung von cephalosporinderivaten
DE2943427A1 (de) Cephalosporinverbindungen
DE3011038A1 (de) Cephalosporinantibiotika
DE2234280A1 (de) Cephalosporinverbindungen und verfahren zu deren herstellung
DE3006777A1 (de) Cephalosporin-antibiotika
AT391319B (de) Verfahren zur herstellung von neuen cephalosporinverbindungen
CH644867A5 (de) In der 3- und 7-stellung substituierte cephemcarbonsaeuren.
DE3784778T2 (de) Cephemverbindungen, ihre herstellung und anwendung.
CH634848A5 (de) Verfahren zur herstellung neuer 7-(n-substituierter 2-phenylglycinamido)-3-substituierte-3-cephem-4-carbonsaeuren.
DE2559932C2 (de) Cephalosporine, Verfahren zur Herstellung derselben und Mittel mit einem Gehalt derselben
DD201142A5 (de) Verfahren zur herstellung von bistetrazolyl-methylsubstituierten cephalosporiantibiotika
EP0054677B1 (fr) Céphalosporines, procédé pour leur préparation et compositions pharmaceutiques les contenant